Volume 30, Issue 4 (Januray 2024)                   JBUMS 2024, 30(4): 371-376 | Back to browse issues page

Research code: 456442
Ethics code: R.BUMS.REC.1400.153


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Naimi F, Allahyari E, Mortazavi Moghaddam S G. The first hospitalization after recovery from COVID-19 and its relationship with Remdesivir treatment: Short Communication. JBUMS 2024; 30 (4) :371-376
URL: http://journal.bums.ac.ir/article-1-3360-en.html
1- Physician, Birjand University of Medical sciences, Vali-e-asrhospital, Birjand, Iran
2- Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical sciences, Birjand, Iran
3- Department of Internal Medicine (Pulmonary Diseases), School of Medicine, Infectious Diseases Research Center, Birjand University of Medical sciences, Birjand, Iran , gmortazavi@yahoo.com
Abstract:   (421 Views)
With the emergence of Corona disease in late 2019, the healthcare network was directly and indirectly affected, and the process and management of patients other than COVID-19 changed. To evaluate some of these changes, the present study was conducted on post-COVID-19 hospital admissions of patients who have been infected with Coronavirus in the past. The census method was used for patients’ recruitment. The collected data was analyzed using descriptive/analytical statistical methods. A total of 202 patients with a mean age of (57.60±18.73) years, including 109 (54%) women and 93 (46%) men, were recruited. The number and percentage of cases admitted in internal, infectious, neurology, and heart wards, were 63 (31%), 52 (25.7%), 35 (17.3%), and 31 (15.3%), respectively. No correlation was found between the history of hospitalization and the type of treatment specific to COVID-19 (Remdesivir) and the disease that led to re-hospitalization after recovery from COVID-19 (P=0.08). Regardless of whether receiving Remdesivir or not, post-COVID-19 hospitalization due to various reasons in internal and infectious wards was the most frequent, respectively, followed by cardiovascular events.
 

*Corresponding Author: Sayyed Gholamreza Mortazavi MoghaddamEmails: gmortazavi@yahoo.com

View ORCID iD Profile

You can also search for this author in:  PubMed     ResearchGate   Scopus    Google Scholar    Google Scholar Profile

Full-Text [PDF 432 kb]   (159 Downloads)    
Type of Study: Short Communication | Subject: Epidemiology
Received: 2023/12/9 | Accepted: 2024/01/27 | ePublished: 2024/02/4

References
1. Webster P. Virtual health care in the era of COVID-19. Lancet. 2020; 395: 1180-1. DOI: 10.1016/S0140-6736(20)30818-7 [DOI:10.1016/S0140-6736(20)30818-7] [PMID]
2. Rodríguez-Leor O, Cid-Álvarez B, Ojeda S, Martin-Moreiras J, Rumoroso JR, Lopez-Palo R, et al. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. Rec Interv Cardiol. 2020; 2: 82-9. DOI: 10.24875/RECICE.M20000123 [DOI:10.24875/RECICE.M20000123]
3. De Filippo O, D'Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med. 2020; 383(1): 88-9. DOI: 10.1056/NEJMc2009166 [DOI:10.1056/NEJMc2009166] [PMID] []
4. Wongtanasarasin W, Srisawang T, Yothiya W, Phinyo P. Impact of national lockdown towards emergency department visits and admission rates during the COVID-19 pandemic in Thailand: A hospital-based study. Emerg Med Australas. 2021; 33(2): 316-23. DOI: 10.1111/1742-6723.13666 [DOI:10.1111/1742-6723.13666] [PMID]
5. Mitchell RD, O'Reilly GM, Mitra B, Smit DV, Miller J-P, Cameron PA. Impact of COVID-19 State of Emergency restrictions on presentations to two Victorian emergency departments. Emerg Med Australas. 2020; 32(6): 1027-33. DOI: 10.1111/1742-6723.13606 [DOI:10.1111/1742-6723.13606] [PMID] []
6. Parra LM, Cantero M, Morrás I, Vallejo A, Diego I, Jiménez-Tejero E, et al. Hospital readmissions of discharged patients with COVID-19. Int J Gen Med. 2020; 13: 1359-66. DOI: 10.2147/IJGM.S275775 [DOI:10.2147/IJGM.S275775] [PMID] []
7. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021; 11(1): 16144. DOI: [DOI:10.1038/s41598-021-95565-8] [PMID] []
8. Rennert-May E, Leal J, Thanh NX, Lang E, Dowling S, Manns B, et al. The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study. PLoS One. 2021; 16(6): e0252441. DOI: 10.1371/journal.pone.0252441. PMID: 34061888; PMCID: PMC8168854. [DOI:10.1371/journal.pone.0252441] [PMID] []
9. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022; 28(3): 583-90. [DOI:10.1038/s41591-022-01689-3] [PMID] []
10. Nevalainen OP, Horstia S, Laakkonen S, Rutanen J, Mustonen JM, Kalliala IE, et al. Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial. Nat Commun. 2022; 13(1): 6152. DOI: 10.1038/s41467-022-33825-5 [DOI:10.1038/s41467-022-33825-5] [PMID] []
11. Jyotsana N, King MR. The Impact of COVID-19 on Cancer Risk and Treatment. Cell Mol Bioeng. 2020 Jun 29; 13(4): 285-291. DOI: 10.1007/s12195-020-00630-3. PMID: 32837583; PMCID: PMC7323371. [DOI:10.1007/s12195-020-00630-3] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb